news
42

A new pill called daraxonrasib has been hailed as the biggest breakthrough in decades for pancreatic cancer after trial results showed one in 12 patients had no detectable cancer and nearly all participants’ tumors stopped growing. The findings suggest a major potential advance against a notoriously hard-to-treat disease.

Only full members can comment

Log in to express your opinion.

No comments yet.